MORTALITY AND ITS RISK FACTORS AMONG IN-PATIENTS WITH INVASIVE ASPERGILLOSIS TREATED WITH VORICONAZOLE. SEATROPH. 2022;53(2):142-150. Accessed April 16, 2026. https://journal.seameotropmednetwork.org/index.php/jtropmed/article/view/551